May 12, 2017 – New study proves safety of novel, wireless pacing system, WiSE CRT (Wireless Stimulation Endocardially for cardiac resynchronization therapy) two years after implantation. The study is the first to report on the medium-long term feasibility of the EBR WiSE cardiac resynchronization therapy (CRT) leadless pacing system for heart failure patients and was presented at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions. 

International Conference for Innovations in Cardiovascular Systems (ICI)

Medtronic plc recently announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one-year data from the WAVES study. Both results were presented by Kathleen Gibson, M.D., of Lake Washington Vascular in Bellevue, Wash., at the 2017 Charing Cross Symposium in London. The new data demonstrate the clinical and quality of life benefits of the Medtronic VenaSeal closure system in treating patients with venous reflux disease.

May 5, 2017 — Northwell Health recently announced that Cindy Grines, M.D., one of the nation’s pre-eminent cardiologists, has joined Northwell Health, New York state’s largest healthcare provider and private employer. She also was appointed chair of cardiology at the Hofstra Northwell School of Medicine.

Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on fingerstick capillary blood are used to support the monitoring of patient oral anticoagulant therapy (OAT) with vitamin K antagonists. These agents include warfarin (Coumadin), phenprocoumon (Marcumar) and acenocoumarol (Sintrom, also sold as other brand names). 

A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found physicians in academic medical centers (AMCs) prescribed fewer of the promoted drugs, and more non-promoted drugs in the same drug classes, following policy changes to restrict marketing activities at those medical centers. The analysis encompassed 16.1 million prescriptions; while the decline observed was modest in terms of percentage, proportionally small changes can represent thousands of prescriptions.

May 5, 2017 — DASpecialists LLC, a provider of data abstraction and support services for mandated or voluntary cardiovascular registries, and cardiovascular information system vendor Lumedx Corp. announced they are partnering to create solutions for cardiovascular data management for U.S. hospitals.

The partnership brings together DASpecialists’ expertise and experienced clinical nurse analysts for both the ACC NCDR and STS data registries with Lumedx’s unique suite of cardiology data analytics, integration and registry tools. 

Heartware HVAD recall for its ventricular assist device from Medtronic

May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist Device (HVAD) system to include an additional product code and instructions to exchange recalled products. The company originally recalled the VAD system in November 2016 recall due to issues with its controller and power connector issues. Additionally, Medtronic announced a new related recall for the HeartWare splice kit intended to repair the HVAD driveline because it may cause electrical issues or stop the pump.

Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that can be caused by open-heart surgery. The findings point to a new potential way to help these hearts recover more completely.

The U.S. House of Representatives on Thursday narrowly approved the American Health Care Act, the legislation designed by House Republican leadership and backed by President Donald Trump to replace the Affordable Care Act (ACA), also known as Obamacare.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now